Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 247379, 8 pages
http://dx.doi.org/10.1155/2008/247379
Review Article

PPAR 饾浘 and PPAR 饾浛 as Modulators of Neoplasia and Cell Fate

Department of Oncology and Lombardi Comprehensive Cancer Center, School of Medicine, Georgetown University, 3970 Reservoir Road, NW, Washington, DC 20007, USA

Received 9 May 2008; Accepted 22 May 2008

Academic Editor: Dipak Panigrahy

Copyright © 2008 Robert I. Glazer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Pooja Pothiwala, Sushil K. Jain, and Subhashini Yaturu, “Metabolic Syndrome and Cancer,” Metabolic Syndrome and Related Disorders, vol. 7, no. 4, pp. 279–287, 2009. View at PublisherView at Google Scholar
  • Jaseena Elikkottil, Divyanshoo R. Kohli, and Kalpna Gupta, “Antitumor activity of a PPAR delta antagonist,” Cancer Biology & Therapy, vol. 8, no. 13, pp. 1262–1264, 2009. View at PublisherView at Google Scholar
  • Sang Hun Lee, Jae Hong Park, Min Young Lee, A. Young Jeong, and Ho Jae Han, “PPAR delta agonist-mediated ROS stimulates mouse embryonic stem cell proliferation through cooperation of p38 MAPK and Wnt/beta-catenin,” Cell Cycle, vol. 8, no. 4, pp. 611–619, 2009. View at PublisherView at Google Scholar
  • Yuzhi Yin, Hongyan Yuan, Xiao Zeng, Levy Kopelovich, and Robert I. Glazert, “Inhibition of Peroxisome Proliferator-Activated Receptor gamma Increases Estrogen Receptor-Dependent Tumor Specification,” Cancer Research, vol. 69, no. 2, pp. 687–694, 2009. View at PublisherView at Google Scholar
  • Claire B. Pollock, Olga Rodriguez, Philip L. Martin, Chris Albanese, Xin Li, Levy Kopelovich, and Robert I. Glazer, “Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation,” PPAR Research, vol. 2010, pp. 1–12, 2010. View at PublisherView at Google Scholar
  • Angelique P. Corthals, “Multiple Sclerosis is Not a Disease of the Immune System,” The Quarterly Review of Biology, vol. 86, no. 4, pp. 287–321, 2011. View at PublisherView at Google Scholar
  • Claire B. Pollock, Yuzhi Yin, Hongyan Yuan, Xiao Zeng, Sruthi King, Xin Li, Levy Kopelovich, Chris Albanese, and Robert I. Glazer, “PPAR delta Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis,” Plos One, vol. 6, no. 1, 2011. View at PublisherView at Google Scholar
  • Jeffrey M. Peters, Yatrik M. Shah, and Frank J. Gonzalez, “The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention,” Nature Reviews Cancer, vol. 12, no. 3, pp. 181–195, 2012. View at PublisherView at Google Scholar
  • Hongyan Yuan, Geeta Upadhyay, Yuzhi Yin, Levy Kopelovich, and Robert I. Glazer, “Stem Cell Antigen-1 Deficiency Enhances the Chemopreventive Effect of Peroxisome Proliferator-Activated Receptor gamma Activation,” Cancer Prevention Research, vol. 5, no. 1, pp. 51–60, 2012. View at PublisherView at Google Scholar
  • X Wang, Y Sun, J Wong, and D S Conklin, “PPARγ maintains ERBB2-positive breast cancer stem cells,” Oncogene, 2013. View at PublisherView at Google Scholar
  • Junfeng Xiao, Bhaskar Kallakury, Yuhzi Yin, Levy Kopelovich, Jin Lu, Rachel Umans, Robert I. Glazer, Hongyan Yuan, Geeta Upadhyay, and Michael E. Fant, “PPAR delta Induces Estrogen Receptor-Positive Mammary Neoplasia through an Inflammatory and Metabolic Phenotype Linked to mTOR Activation,” Cancer Research, vol. 73, no. 14, pp. 4349–4361, 2013. View at PublisherView at Google Scholar
  • Chelsea Q. Xu, Suzanne M. de la Monte, Ming Tong, Chiung-Kuei Huang, and Miran Kim, “ Chronic Ethanol-Induced Impairment of Wnt/ β -Catenin Signaling is Attenuated by PPAR- δ Agonist ,” Alcoholism: Clinical and Experimental Research, 2015. View at PublisherView at Google Scholar
  • Robert I. Glazer, “ PPAR δ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance ,” PPAR Research, vol. 2016, pp. 1–7, 2016. View at PublisherView at Google Scholar
  • Chenglong Huang, Shiran Gou, Lei Wang, Kui Huang, Lin Liu, Wenjie Zhao, Lige Zheng, and Jingang Xiao, “MicroRNAs and Peroxisome Proliferator-Activated Receptors Governing the Differentiation of Mesenchymal Stem Cells,” Current Stem Cell Research & Therapy, vol. 11, no. 3, pp. 197–207, 2016. View at PublisherView at Google Scholar
  • Robert I. Glazer, and Levy Kopelovich, “PPARs as determinants of the estrogen receptor lineage: Use of synthetic lethality for the treatment of estrogen receptornegative breast cancer,” Oncotarget, vol. 8, no. 31, pp. 50337–50341, 2017. View at PublisherView at Google Scholar